New therapeutic strategies based around the use of anti-inflammatory drugs (e.g. anti-TNF-alpha antibodies, pentosan polysulfate) for the treatment of joint disease may be promising approaches [10, 33, 45]. The gene discussed is TNF; the disease is arthropathy.